← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2005Last known activity
Nov 30, 2020
Timeline
1960s
- Jun 1, 1969
Ophthalmic Consultants of Boston— Founded
Drugs by trial phase (18 distinct, 16 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Cataract
- Central Serous Chorioretinopathy
- Choroidal Neovascularization
- Communicable Diseases
- Conjunctivitis
- Conjunctivitis, Allergic
- Diabetic Retinopathy
- Drug Hypersensitivity
- Edema
- Eye Infections
- Geographic Atrophy
- Infections
- Macular Degeneration
- Macular Edema
- Neovascularization, Pathologic
- Pseudophakia
- Retinal Diseases
- Retinal Vein Occlusion
- Retinitis
- Retinitis Pigmentosa
- Tissue Adhesions
- Uveitis
- Uveitis, Anterior
Recent trials (25)
- NCT04604899Overall official - principal investigatorPhase 2Nov 30, 2020
- NCT03066258Overall official - principal investigatorPhase 1Mar 31, 2017
- NCT03144999Overall official - principal investigatorPhase 1Mar 29, 2017
- NCT02462889Overall official - principal investigatorPhase 2Jun 1, 2015
- NCT02462889Lead sponsorPhase 2Jun 1, 2015
- NCT02462889Sponsor investigatorPhase 2Jun 1, 2015
- NCT02354170CollaboratorPhase 2Jan 1, 2015
- NCT02354170Overall official - principal investigatorPhase 2Jan 1, 2015
- NCT02245516Overall official - principal investigatorN/AJul 1, 2014
- NCT01966328Sponsor investigatorPhase 1Oct 1, 2013
- NCT01966328Overall official - principal investigatorPhase 1Oct 1, 2013
- NCT01966328Lead sponsorPhase 1Oct 1, 2013
- NCT01724554Lead sponsorPhase 1/Phase 2Nov 1, 2012
- NCT01724554Overall official - principal investigatorPhase 1/Phase 2Nov 1, 2012
- NCT01193504Overall official - principal investigatorPhase 4Sep 1, 2010
Details
- Founded
- Boston, MA, US Jun 1, 1969
- Last known activity
- Nov 30, 2020